February 8, 2010 -- 3SBio Inc. in-licensed the China rights to a phosphate binder, Nephoxil®, from Panacor Bioscience Ltd. of Taiwan. Phosphate binders are routinely prescribed for end stage renal disease, the same population served by 3SBio’s major products, the recombinant anemia drugs EPIAO and TPIAO. More details...
